Brian Thorsen is the Director of the PSC Partners Patient Registry. He received his B.A. in Statistics from UC Berkeley, and began his career in math education. Since his PSC diagnosis in 2020, and joining PSC Partners staff in 2022, he has been working to empower patients like him to be active participants and collaborators in research.

I completed medical school at Tufts University school of Medicine, Internal Medicine residency at University of Pennsylvania, and Gastroenterology and Transplant Hepatology fellowships at Yale University. I am an attending transplant hepatologist at the University of Washington where I serve as the medical director for Northwest Hepatology and as core faculty for the GI fellowship. I am also a part of a multidisciplinary group for hereditary hemorrhagic telangiectasia working to build a center of excellence.

I grew up in Mexico City whereI completed my medical school education at Anahuac University in Mexico City, where I developed a strong foundation in medicine and a passion for patient care. After medical school, I moved to the United States to pursue my residency and fellowship training. Following my training, I joined Beth Israel Deaconess Medical Center (BIDMC), where I have had the privilege of building my career.

Hepatologist, Professor of Medicine and Head of the Division of Hepatology, Liver and Liver Transplant Clinic at Groote Schuur Hospital and the Univeristy of Cape Town, Cape Town, South Africa.

Dr. Jones, a Hepatologist and Associate Professor of Clinical Medicine, trained at the University of North Carolina for Gastroenterology and Transplant Hepatology. She joined University of Miami faculty in 2015. She takes a multi-pronged approach to researching disparities in hepatocellular carcinoma (HCC) and chronic liver disease. She used community-based participatory research to test the feasibility and acceptability of home-based hepatitis B screening. Dr.

I am a physician-scientist and hepatologist at the University of Southern California with a research interest in Drug-Induced Liver Injury and Autoimmune Liver Diseases. I study mechanisms of liver injury and hepatotoxicity with a particular focus on cell death pathways using basic, animal model, and translational approaches. My lab currently focuses on Immune-mediated Liver Injury from Checkpoint Inhibitors and the complex interplay if signaling mechanisms leading to hepatotoxicity in immunotherapy.

I studied Medicine at the Catholic University of Louvain in Belgium. A fter graduating in 1982, I completed an Internal Medicine Residency in New York City. Thereafter, I entered the Gastroenterology and Hepatology Fellowship at the University of Southern California (USC), graduating in 1989. My professional career started at the University of Missouri-Kansas City, followed by a return at USC from 1992-2001 and a Liver Transplant position at California Pacific Medical Center from 2002-2012.

Allison Kwong is a hepatologist who specializes in the care of patients with chronic liver disease. Her research in alcohol-associated liver disease has been supported by the AASLD Foundation Clinical, Translational, and Outcomes Research Award and a NIAAA K23 Mentored Career Development Award. Her clinical and research interests include cirrhosis, portal hypertension, and outcomes before and after liver transplantation.

PGY3 at UMass